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The synthesis and structure of chelating amido-NHC and amido-bis(NHC) complexes of Pd 
and Pt are described, including the first [CNC]Pt complexes and the first Pd arylamido-NHC 
complex. 
Abstract  
With a view to applications in bifunctional catalysis, a modular cross-coupling strategy has 
been used to prepare amine bis(imidazolium) salts (3a and 3b) and an amine 
mono(imidazolium) salt (6) as precursors to chelating amido-NHC ligands. Treating the pro-
ligands 3 with 3 equivalents of the bulky base KHMDS and Pd(OAc)2 or PtCl2(COD) gave the 
four amido bis(N-heterocyclic carbene) pincer complexes [CNC-R]M-I [M = Pd (7) or Pt (8); R 
= i-Pr (a) or n-Bu (b)], including the first examples of platinum complexes of a CNC ligand. The 
reaction of 7a with AgOTf in pyridine gave the cationic complex {[CNC-i-Pr]Pd-py}OTf (9a). 
Heating a mixture of amine mono(imidazolium) salt 6 with PdCl2 or K2PtCl4, K2CO3 and KI in 
pyridine at 100 °C gave the complexes [C,NH]MI2py [M =Pd (10) or Pt (11)], in which the 
amine arm of the NHC ligand is not deprotonated and does not coordinate to the metal. For a 
solution of 10 in 1,4-dioxane, deprotonation of the amine occurred in a biphasic reaction with 
aqueous KOH at 40 °C, giving the dimeric amido complex {[C,N]Pd(µ-OH)}2 (12). The more 
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inert Pt analogue 11 was unreactive under the same conditions. Solid-state structures of the 
complexes 7a, 7b, 9a, 10, 11 and 12 have been determined by single crystal X-ray diffraction. 
Introduction 
Bifunctional catalysis, in which an electrophilic metal and a nucleophilic ligand act in concert to 
activate a substrate, enables reactions to take place that are not possible using classical 
catalytic transformations that occur only at the metal centre.1–3 Wide-ranging applications have 
been found for bifunctional catalysis, many in asymmetric synthesis, including hydrogenation 
under H2,4 transfer hydrogenation,5,6 isomerisation of allylic alcohols,7 alkene hydroamination,8 
hydrosilylation,9 Michael addition,10 C-H activation11–15 and lactide polymerisation.16 The most 
studied of these reactions is the asymmetric transfer hydrogenation between alcohols and 
carbonyl compounds, catalysed by half-sandwich complexes of Ru, Ir or Rh with a chiral 
diamine ligand such as N-tosyl-1,2-diphenylethylenediamine. The key steps in the catalytic 
cycle occur after deprotonation of the primary amine group to give a metal amido complex: 
subsequent transfer hydrogenation from i-PrOH to the M-N bond gives a metal amine-hydride 
complex that transfers an acidic and a basic hydrogen to the carbonyl substrate.17 Crucially, 
the chelating amine ligand makes the catalyst more resistant to undesirable M-N bond 
cleavage.18 Other chelating groups such as aryl,19 phosphine20–22 and thiol/thioether23 have also 
been used to tether the reactive nitrogen to the metal in transfer hydrogenation. However, the 
application of N-heterocyclic carbene (NHC) donor groups to tether a nucleophilic amido 
ligand to an electrophilic metal in bifunctional catalysis has yet to be fully exploited,24,25 and 
even simple coordination chemistry of multidentate amido-NHC ligands is under-explored. Of 
note, tridentate bis(amido)-NHC [NCN] pincer complexes of zirconium and hafnium have been 
reported,26,27 and amido-bis(NHC) [CNC] and amido-NHC [C,N] complexes of some early and 
late transition metals are also known.28–35 Most closely related to this work, Douthwaite has 
described the palladium [CNC] complex A and, during the course of our research, Luo has 
reported the Pd complexes (B).36,37 
Fig. 1 
As part of a research programme exploring new applications in bifunctional catalysis, we have 
been investigating late transition metal complexes containing amido-NHC ligands. Herein, we 
report tridentate amido-bis(NHC) [CNC] ligand complexes of palladium and for the first time 
platinum. We also report the first bidentate arylamido-NHC [C,N] ligand complex of palladium. 
Results and Discussion 
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The synthesis of the amine bis(imidazolium) pro-ligands proceeded with a palladium catalysed 
amination of 2-bromoiodobenzene to give bis(2-bromophenyl)amine (1) using a procedure 
adapted from the literature (Scheme 1).38 A copper catalysed Ullman-type reaction39 of 
imidazole with 1 gave the coupled product 2 in 90% yield. Subsequent alkylation of 2 with i-
propyliodide or n-butyliodide gave the imidazolium iodide salts 3a and 3b in 89 and 93% yields 
respectively. As expected, the alkylation reaction proceeded faster for the primary alkyl halide 
than the secondary alkyl halide. Hence, the pro-ligands 3a and 3b were prepared in three 
steps in 74-78% yield from commercially available materials. 
Scheme 1. 
The same methodology was also applied to prepare an analogous pro-ligand containing only 
one imidazolium moiety: starting instead from N-(2-bromophenyl)-2,6-diisopropylaniline (4),40 
the Ullman-type cross coupling with imidazole gave intermediate 5 and subsequent alkylation 
with i-propyl iodide gave the imidazolium pro-ligand 6 (Scheme 2).  
Scheme 2. 
A common method for the coordination of N-heterocyclic carbene ligands to transition metals 
is to prepare the silver(I) NHC complex from the reaction of an imidazolium salt and Ag2O; 
subsequent transmetallation then gives the required metal-NHC complex.41,42 Douthwaite et al. 
have shown that this is a viable route to the complex A.36 However, treating our more rigid pro-
ligands 3a or 3b with Ag2O in DCM at room temperature gave an intractable mixture of 
products. Performing the reaction in refluxing THF also gave an unidentifiable mixture, as did 
including Pd(OAc)2 or PdCl2(COD) in the reaction mixture. Conversely, Luo et al. have 
reported that treatment of an amine bis(imidazolium) salt with Ag2O followed by PdCl2(MeCN)2 
gave the corresponding [CNC]PdCl complexes B, although a silver complex of their ligands 
could not be isolated.37 Presumably, a silver(I) NHC complex was generated in situ., and 
subsequent transmetallation to Pd was successful. For our ligands, however, this strategy also 
proved to be unsuccessful. 
Luo reported that the preparation of [CNC] pincer complexes of palladium B by deprotonation 
of the amine bis(imidazolium) ligand with an organometallic or amide base were 
unsuccessful.37 In contrast, we found that treating a DME solution of 3a or 3b with 3 
equivalents of potassium hexamethyldisilazide (KHMDS) at 0 °C in the presence of Pd(OAc)2 
gave, after work-up and purification by column chromatography, the complexes [CNC-i-Pr]Pd-I 
(7a) and [CNC-n-Bu]Pd-I (7b) in 33 and 42% yields respectively, Scheme 3. These moderate 
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yields do not appear to arise from the purification procedure: the 1H NMR spectrum recorded 
for the crude product showed several other species that could not be identified and repeating 
the column chromatography gave complete recovery of analytically pure material. Using 
PdCl2(COD) in the reaction instead of Pd(OAc)2 or using THF as the solvent gave lower yields, 
and performing the reaction in the absence of a palladium salt gave an intractable mixture of 
products. Coordination of the anionic tridentate bis(N-heterocylic carbene) ligand to palladium 
was confirmed by 1H and 13C NMR spectroscopy: the 1H NMR spectra for 7a and 7b lack a 
signal that could be assigned to the NCHN proton of an imidazolium cation (these were 
present as singlet resonances at δH 9.56 and 9.72 ppm respectively in the spectra recorded for 
3a and 3b) and the 13C{1H} NMR spectra for 7a and 7b contained signals at δ 165.3 and 167.0 
ppm respectively for the carbene bound to palladium. An unexpected feature of the 1H NMR 
spectrum recorded for 7a was the downfield shift observed for the i-Pr CH resonance, which 
appeared as an apparent septet at 6.35 ppm. The ligand completing the fourth coordination 
site at Pd was confirmed as iodide by FAB MS and microanalysis.  
Scheme 3. 
Crystals of 7a and 7b suitable for single crystal X-ray diffraction were obtained by the slow 
evaporation of a C6D6 solution of each; ORTEP figures for the solid state structures are shown 
in Figures 2 and 3 and selected bond lengths are shown in Table 1. 
Table 1. 
Fig. 2. 
Fig. 3. 
The complexes 7a and 7b both display the expected square planar geometry around Pd and 
iodide is confirmed as the ligand filling the fourth coordination site. The [CNC] ligand is 
strongly distorted from planarity: the angle between the square plane around Pd and the 
trigonal plane around the amide nitrogen is 53.3 ° in 7a and 57.4 ° in 7b. Hence, the ligand 
adopts a helical conformation and two atropisomers arise. Complex 7a crystallizes in the non-
centrosymmetric chiral space group C222(1), and only one enantiomer is present in the unit 
cell. Complex 7b, however, crystallizes in the non-centrosymmetric achiral space group Aba2, 
and hence both enantiomers are observed in the unit cell. Atropisomerism has been observed 
for pyridyl and aryl bridged NHC pincers and rapid interconversion of the atropisomers is 
common.29,43,44 In addition, the [CNC]PdCl complex A and the related amine complex 
{[CN(H)C]PdCl}Cl also show interconversion of atropisomers at ambient temperature.36,45 
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Conversely, variable temperature 1H NMR spectra recorded for 7a in C6D6 up to 344 K 
showed no coalescence of the diastereotopic methyl groups or indeed any line broadening 
consistent with fluxionality. Hence, these [CNC] palladium complexes appear to possess 
greater stereochemical rigidity that could enable new strategies for the synthesis of non-
racemic chiral complexes from achiral ligands.46 
The Pd-N bond lengths in the two complexes 7a and 7b are typical for a Pd(II)-amide bond 
and the Pd-C bond lengths are also typical for two trans NHC ligands bound to square planar 
palladium.47 These bond lengths do not differ significantly from those reported for the 
complexes B by Luo.37 There is a large angle (7a: 81.3 °; 7b: 78.3 °) between the planes of the 
two NHC ligands. In turn, the plane of each NHC ring lies at an angle of ca. 40 ° to the square 
plane around Pd (7a: 41.1 °; 7b: 38.7, 41.2 °). Although two trans NHC ligands will often lie in 
the same plane as each other, a large angle between these two planes – either as forced by 
the conformation of a pincer ligand or as the result of steric interactions between bulky NHCs 
and the cis ligands - is not uncommon; the torsion angle between the two trans NHC rings has 
no correlation with the Pd-C bond length, as would be expected for a purely σ-bonding 
interaction between palladium and the carbene.47 
In 7a there is a very short H---I contact (2.859 Å) between the methyne hydrogen of the i-
propyl substituent and the iodide ligand. This H-bonding interaction also appears to be present 
in solution, as there is a large downfield shift (δH 6.35 ppm) for the signal arising from this 
proton in the 1H NMR spectrum for 7a. Similar short H---I distances are observed for 7b (2.789 
and 2.917 Å). 
We found that the coordination chemistry could be extended from palladium to platinum. 
Hence, reacting the imidazolium salts 3a or 3b with PtCl2(COD) and 3 equivalents of KHMDS 
gave the analogous platinum pincer complexes [CNC-i-Pr]Pt-I (8a) or [CNC-n-Bu]Pt-I (8b), 
although the yields were poor, Scheme 3. As for 7a and 7b, iodide rather than chloride 
occupies the fourth coordination site, as confirmed for both complexes by mass spectrometry 
and microanalysis. Coordination of the tridentate pincer ligand to platinum gave similar NMR 
spectra to the Pd complexes: in particular, the 13C NMR spectrum recorded contained 
characteristic singlets at 162.5 ppm (8a) and 164.0 ppm (8b) corresponding to the carbene. 
Moreover, for 8a the apparent septet corresponding to the i-Pr CH was shifted downfield to 
6.38 ppm, indicating that a H-bonding interaction with the iodide ligand is also present in the Pt 
complex. Therefore, although we have thus far been unable to grow crystals of 8a or 8b 
suitable for X-ray crystallography, the data we have obtained indicates that the complexes 
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have a very similar structure to those of their palladium analogues. Although several pincer 
carbene complexes of Pd have been reported, platinum pincer carbene complexes are 
surprisingly rare,48,49 and these are the first reported platinum [CNC] complexes.  
We were interested to see if the halide ligand could be replaced with a neutral donor in a 
cationic complex. When 7a was dissolved in d5-pyridine the 1H NMR spectrum indicated the 
presence of two different complexes. One of these complexes exhibited an apparent septet 
attributable to the i-Pr group at 6.40 ppm (which we assign, by the downfield shift, as 7a) 
whereas the other exhibited an apparent septet at 3.68 ppm. The addition of 1.5 equivalents of 
silver triflate to this solution gave quantitative conversion to the latter complex (Scheme 3), 
which we subsequently identified as the triflate salt {[CNC-i-Pr]Pd-py}OTf (9a) by single crystal 
X-ray diffraction. The solid-state structure of 9a is shown in Figure 4 and selected bond 
lengths are shown in Table 1. Unfortunately the crystal was weakly diffracting and hence the 
data is weak; the crystal also contained disordered dichloromethane. Despite this, it is possible 
to discuss the prominent structural features of 9a. The geometry around Pd is square planar, 
with the tridentate pincer and a molecule of pyridine bound to the metal. The triflate anion is 
not coordinated to Pd, and also shows significant disorder in the crystal, requiring the splitting 
of one of the F atoms in one of the triflate ions. It is apparent that there is still a significant twist 
in the [CNC] ligand: in the two independent molecules of 9a present in the unit cell the angle 
between the square plane around the metal and the trigonal planar amide nitrogen is 49.9 and 
49.4 ° and the torsion angle between the planes of the two trans NHC ligands is 72.8 and 
70.5 °. There are no significant differences between the metal amide and metal carbene bond 
lengths in the iodide complex 7a or the cation 9a. Our attempts to isolate an analytically pure 
sample of 9a on a larger scale were unsuccessful as it was not possible to completely 
separate 9a from pyridine.  
Fig. 4. 
The strategy described above for the coordination of the [CNC] ligands to Pd and Pt was also 
attempted with the amine mono(imidazolium) pro-ligand 6, but NHC complexes could not be 
isolated under these conditions. Alternatively, treating 6 with K2CO3, PdCl2 and potassium 
iodide in refluxing pyridine gave [C,NH]PdI2py (10) as a yellow-orange solid in 89% yield after 
column chromatography (Scheme 4). Performing the reaction with K2PtCl4 instead of PdCl2 
gave the platinum analogue [C,NH]PtI2py (11) as yellow crystals in 47% yield. Scheme 4.  
The solid-state structures of both 10 and 11 were determined by single crystal X-ray diffraction 
(Figures 5 and 6; selected bond lengths are given in Table 2). The structure of 10 is very 
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similar to the structures of trans-(NHC)PdI2py complexes that have been reported 
previously.50–53 The NHC-amine ligand in both complexes is only bound to the metal through 
the carbene; the amine nitrogen is not coordinated. The inner coordination sphere is 
completed by two trans iodide ligands and a pyridine ligand. In 10, the bond lengths and 
angles around the square planar Pd are extremely similar for the two independent molecules 
found in the unit cell, despite the two molecules having very different angles between the 
mean plane of the NHC and pyridine ring (14.9 and 40.2 °). The Pd–C bond lengths (1.957(7) 
and 1.981(7) Å) are shorter than for the pincer complexes, demonstrating the weaker trans 
influence of the pyridine ligand in 10 compared with the NHC in 7a, 7b and 9a. The unit cell for 
11 also contains two unique molecules, which like 10 differ greatly with respect to the angle 
between the mean plane of the NHC ring and the pyridine ring (19.8 and 38.7 °). However, 
both of the unique molecules show very similar bond lengths around Pt (e.g. d(Pt–C) are 
1.965(13) and 1.968(11) Å).  
The signals arising from the carbene are difficult to assign in the 13C NMR spectra for 10 and 
11. For 10, the signal at 147.3 ppm is most likely the carbene resonance, as the nearby 
signals for 4° carbons at 146.6 and 148.0 ppm are broad like the signals we can 
unambiguously assign as arising from the 2,6-diisopropylphenyl group. Likewise for 11, the 
carbene resonance appears to be the sharp signal at 143.6 ppm, rather than one of the broad   
4° C signals at 147.2 and 148.2 ppm (unfortunately 195Pt satellites, which would have aided 
the identification of the carbene resonance, could not be observed). These signals fall into the 
range previously reported for carbenes in trans-(NHC)MX2py (M = Pd or Pt) complexes.51,52,54 
Fig. 5.  
Fig. 6. 
Table 2. 
Pre-catalysts of the type trans-(NHC)PdI2py (PEPPSI catalysts: Pyridine-Enhanced Pre-
catalyst Preparation, Stabilization and Initiation) deliver excellent activity in cross-coupling 
reactions;55–57 complexes with NHC ligands that are functionalised with carbonyl (amide50–52 and 
ketone52), alcohol and ether groups51,53 have also been reported previously, but, to the best of 
our knowledge, 10 is the first amine functionalised complex of this type. Furthermore, the 
nucleophilic substitution reactions of alkyl or benzyl halides used to prepare the functionalised 
NHC ligands in these previously reported complexes contrasts with the cross-coupling strategy 
used to synthesise the pro-ligand 6, which enables efficient access to aryl substituted NHC 
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ligands with the functional group (amine) also bound to the aromatic ring. Platinum analogues 
of these Pd catalysts have been reported,54 but these are much less common. 
We first attempted to deprotonate the amine group in 10 to yield an amido-NHC complex using 
KHMDS as the base. Surprisingly, the novel dimeric amido complex {[C,N]Pd(µ-OH)}2 (12) 
was the only compound that could be isolated from this reaction. Presumably the hydroxide 
ligand was produced from adventitious moisture, but the reaction showed poor reproducibility, 
even when an excess of water was added to a rigorously dry reaction mixture. Alternatively, 12 
could be isolated in good yield by stirring a solution of 10 in 1,4-dioxane with aq. KOH, 
Scheme 4. The IR spectrum recorded for 12 contains a weak resonance at 3601 cm-1 that is 
consistent with the bridging hydroxide ligand.  
The solid-state structure of 12 was determined by single crystal X-ray diffraction (Fig. 7; 
selected bond lengths are given in Table 2). Two crystallographically equivalent monomer 
units make up the dimer in 12, with a non-bonding Pd(1)···Pd(1’) distance of 3.2348(6) Å. The 
Pd2O2 ring is almost planar, with a Pd-O-Pd-O torsion angle of 4.7 °, but the two Pd–O bond 
lengths are different, with the bond trans to the NHC (2.086(2) Å) ca. 0.03 Å longer than the 
bond trans to the amido ligand (2.052(2) Å) due to the stronger trans influence of the carbene. 
A search of the Cambridge Structural Database for complexes of the type [L1L2Pd(µ-OH)]2 
revealed that the Pd–O bond length tends to correlate with the Lewis basicity of the trans 
ligand.47 Hence, the shortest Pd–O distances (2.005(2) to 2.016(3) Å) have been observed 
with a pyridine or imine donor trans to µ-OH;58–61 the database contained no examples of NHC 
or amido ligands in complexes of this type, but the Pd–O bond lengths in 12 are similar to 
those reported for complexes with a phosphine trans to the µ-OH ligand,62–64 and the longest 
Pd–O distance (2.126 Å) is for µ-OH trans to a phenyl ligand.65 
Fig. 7. 
Table 2. 
Both the metal-amide (1.998(3) Å) and metal-carbene (1.945(3) Å) distances are the shortest 
for all the complexes that we report herein. Unusually for a metal hydroxide, there is an 
absence of H-bonding in the solid state, which may be a consequence of the bulky N-aryl and 
N-alkyl substituents that surround the hydroxide ligand. The bridging hydroxide ligand can be 
clearly identified in the 1H NMR spectrum for 12 at δH –3.97 ppm, slightly upfield of the typical 
range of ca. –0.25 to –3.5 ppm for cationic and neutral Pd(µ-OH)2 moieties.62,66–69 In the 
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previously reported β-diiminato complex {[Ph2nacnac]Pd(µ-OH)}2 the OH signal was observed 
even further upfield at –5.24 ppm, most likely as a consequence of the shielding effect of the 
two nearby phenyl groups of the Ph2nacnac ligands.69 Likewise, the 2,6-diisopropylphenyl 
group in 12 also appears to shield the bridging hydroxide, which sits ca. 2.54 Å above the 
aromatic ring in the solid state. In the 13C NMR spectrum for 12, the carbene signal could not 
be clearly identified as there are four signals for 4° C atoms between δ 144-148 ppm. 
Palladium complexes of a bidentate amido-NHC ligand have been reported for an amido donor 
that is derived from deprotonation of an N-acyl group.50 However, to the best of our knowledge, 
compound 12 is the first reported Pd complex of either an arylamido or alkylamido 
functionalised NHC ligand. 
We attempted to prepare the platinum analogue of 12 by also treating a solution of 11 in 1,4-
dioxane with aqueous KOH at 40 °C, but 11 was unreactive under these conditions. This 
observation is consistent with a mechanism where hydroxide reacts at the metal first and 
follows the common trend that ligand substitution reactions are slower for Pt than Pd.70–72 
Increasing the temperature of the reaction to 60 °C gave complete conversion of 11 to a 
mixture of products, but we were unable to isolate a pure compound from this reaction. 
Conclusions 
We have prepared precursors to bidentate amido-NHC [C,N] and tridentate amido-bis(NHC) 
[CNC] ligands in high yield using an efficient sequence of two cross-coupling reactions and an 
alkylation. Different strategies were required to coordinate these ligands to Pd and Pt. For the 
[CNC] ligands, reaction of the amine bis(imidazolium) salts 3 with KHMDS and either 
Pd(OAc)2 or PtCl2(COD) enabled the isolation of the palladium complexes [CNC-i-Pr]Pd-I (7a) 
and [CNC-n-Bu]Pd-I (7b) and the first [CNC] platinum complexes [CNC-i-Pr]Pt-I (8a) and 
[CNC-n-Bu]Pt-I (8b); treating 7a with AgOTf in pyridine also gave the cationic complex [CNC-i-
Pr]Pd(py)}OTf 9a with pyridine bound in the fourth site. For the [C,N] ligand, reaction of the 
amine mono(imidazolium) salt 6 with PdCl2 or K2PtCl4, K2CO3 and KI in pyridine at 100 °C 
gave the complexes [C,NH]MI2py [M =Pd (10) or Pt (11)], in which the amine arm of the NHC 
ligand is not deprotonated and does not coordinate to the metal. The amine group in 10 was 
deprotonated in a biphasic reaction with aqueous KOH at 40 °C, giving the dimeric amido 
complex {[C,N]Pd(µ-OH)}2 (12), the first reported arylamido-NHC complex of palladium. Under 
the same conditions, the more inert Pt analogue 11 was unreactive. We are currently 
investigating the reactivity of these ligands and complexes with a view to applications in 
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bifunctional catalysis. 
Experimental 
All manipulations were performed under dry, oxygen free nitrogen using standard Schlenk 
techniques unless otherwise stated. THF and toluene were dried by passing through a column 
of activated alumina and then degassed; DME was pre-dried over sodium and distilled from 
Na-benzophenone; anhydrous DMF was purchased from Sigma-Aldrich and used as supplied; 
KHMDS was purchased as a solution in toluene and titrated against 4-phenylbenzylidene 
benzylamine.73 Bis(2-bromophenyl)amine (1),38 N-(2-bromophenyl)-2,6-diisopropylaniline (4)40 
and PtCl2(COD)74 were prepared as reported in the literature. All other reagents were obtained 
from Sigma-Aldrich, Johnson Matthey or Alfa Aesar and used as supplied. NMR spectra were 
recorded on a Bruker DPX300, DRX400 or AV500 spectrometer; chemical shifts have been 
referenced to the residual protonated solvent peak and J values are given in Hz. IR spectra 
were run in a diamond ATR cell using a Perkin Elmer Spectrum 1 instrument. ESI mass 
spectra were recorded on a micromass Quattra LC spectrometer in MeCN/MeOH with a cone 
voltage of +50 or -25 V unless stated; FAB mass spectra were obtained on a Kratos concept 
spectrometer using NBA as the matrix. Elemental analyses were performed at London 
Metropolitan University. 
Bis(2-(1H-imidazol-1-yl)phenyl)amine (2) 
Compound 1 (2.97 g, 9.10 mmol), imidazole (1.24 g, 18.2 mmol), Cs2CO3 (11.86 g, 36.40 
mmol), CuI (0.346 g, 1.82 mmol) and 8-hydroxyquinoline (0.264 g, 1.82 mmol) were 
suspended in DMF (5 mL) in a pre-dried sealable tube. The tube was sealed and heated at 
125 °C for 15 h. The reaction mixture was then allowed to cool to room temperature and 
diluted with DCM (50 mL). The mixture was filtered through a pad of Celite and washed with a 
solution of 5% LiCl(aq.) (5 x 100 mL) and brine (2 x 50 mL). The solution was then dried 
(MgSO4) and the volatiles removed in vacuo to give a green solid (2.47 g, 90%) m.p. 80-82 °C. 
δH(500 MHz, CD2Cl2) 5.12 (1H, s, NH), 7.11 (2H, t, J = 7.8, Ar CH), 7.24–7.32 (4H, m, Ar CH), 
7.36 (2H, t, J = 7.8, Ar CH), 7.75 (br, imidazole CH); δC(67.9 MHz, CDCl3) 119.3, 122.6, 127.6, 
129.7, 137.7. υmax/cm-1 (solid) 3116 w, 3096 w, 2914 w, 1593 m, 1510 s, 1500 s, 1482 s, 1459 
m, 1312 s, 1278 m, 1236 w, 1108 m, 1088 w, 1059 s, 963 m, 907 m, 821 m, 772 s. m/z (ESI) 
302 (100%, M+H+), 324 (21% M+Na+); HRMS C18H16N5 calcd. 302.1400, found 302.1414. 
Compound 2 could not be isolated in analytically pure form, but this did not hinder subsequent 
steps. Some signals are broad or not apparent in the NMR spectra; we speculate that this is 
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due to inter- and intramolecular H-bonding. 
Bis(2-(3-iso-propyl-1H-imidazolium)phenyl)amine diiodide (3a) 
In a sealable tube under an atmosphere of air, i-propyl iodide (0.36 mL, 3.7 mmol) was added 
to a green suspension of 2 (0.500 g, 1.66 mmol) in MeCN (10 mL). The tube was sealed and 
heated at 90 °C for 24 h, giving a red solution. The mixture was allowed to cool to RT and 
filtered. The volatiles were removed in vacuo to give an orange solid (0.951 g, 89%) m.p. 81-
84 °C. δH(300 MHz, CDCl3) 1.70 (12H, d, J = 6.7, CH(CH3)2), 4.97 (2H, sept, J = 6.7, 
CH(CH3)2), 7.14 (2H, dt, 3J = 7.8, 4J = 1.2, CH), 7.30 (2H, dd, 3J = 7.9, 4J = 1.2, CH), 7.36 (2H, 
dd, 3J = 7.8, 4J = 1.5, CH), 7.46 (2H, dt, 3J = 7.9, 4J = 1.5, CH), 7.53 (2H, t, J = 1.7, NCHCHN), 
7.75 (2H, t, J = 1.7, NCHCHN), 9.56 (2H, t, J = 1.7, NCHN); δC(67.9 MHz, CDCl3) 22.9 
(CH(CH3)2), 52.8 (CH(CH3)2), 121.5, 122.9, 123.8, 124.2, 126.1, 127.7, 132.0, 135.6, 137.7 
(aromatic C). υmax/cm-1 (solid) 3066 w, 2978 w, 1597 m, 1546 m, 1497 s, 1458 m, 1375 w, 
1305 m, 1264 w, 1192 s, 1161 w, 958 w, 875 w, 827 w, 758 vs, 681 w, 650 s. m/z (ESI) 514 
(18%, [M-I]+), 386 (100% [M-I-HI]+), 344 (36%, [M-I-HI-iPr]+); HRMS C24H29I2N5 calcd. 
514.1462, found 514.1465. Anal. Calcd. for C24H29I2N5: C, 44.95; H, 4.56; N, 10.92. Found C, 
45.01; H, 4.27; N, 10.61%. 
Bis(2-(3-butyl-1H-imidazolium)phenyl)amine diiodide (3b) 
In an identical procedure to that used for 3a, 3b was prepared from n-butyl iodide (0.940 g, 
5.11 mmol) and 2 (0.700 g, 2.33 mmol) in MeCN (10 mL). The tube was sealed and heated at 
90 °C for 15 h, giving a red solution. The mixture was allowed to cool to RT and filtered. The 
volatiles were removed in vacuo to give 3b as a light brown solid (1.450 g, 93%) m.p. 56-57 
°C. δH(400 MHz, CDCl3) 0.95 (6H, t, J = 7.5, CH3), 1.36 (4H, apparent sext, J = 7.5, CH2), 1.92 
(4H, apparent quint, J = 7.5, CH2), 4.40 (4H, t, J = 7.5, CH2), 7.10 (2H, t, J = 7.6, CH), 7.25 
(2H, d, J = 7.6, CH), 7.39 (2H, d, J = 8.2, CH), 7.44 (2H, t, J = 8.2, CH), 7.56 (2H, t, J = 1.5, 
NCHCHN), 7.66 (2H, t, J = 1.5, NCHCHN), 9.72 (2H, s, NCHN); δC(100 MHz, CDCl3) 13.6 
CH3, 19.6 CH2, 31.6 CH2, 50.5 CH2, 122.8, 123.6, 123.8, 123.9, 126.1, 127.6, 132.1, 136.7, 
137.7 (aromatic C). υmax/cm-1 (solid) 3066 w, 2978 w, 1597 m, 1546 m, 1497 s, 1458 m, 1375 
w, 1305 m, 1264 w, 1192 s, 1161 w, 958 w, 875 w, 827 w, 758 vs, 681 w, 650 s. m/z (ESI) 542 
(34%, [M-I]+), 414 (100% [M-I-HI]+), 358 (30%, [M-I-HI-Bu]+); HRMS C26H33IN5 calcd. 
542.1781, found 542.1770. Anal. Calcd. for C26H33I2N5: C, 46.65; H, 4.97; N, 10.46. Found C, 
46.25; H, 4.70; N, 10.13%. 
N-(2-(1H-imidazol-1-yl)phenyl)-2,6-diisopropylaniline (5) 
 12 
Compound 4 (2.00 g, 6.01 mmol), imidazole (0.409 g, 6.01 mmol), Cs2CO3 (3.916 g, 12.02 
mmol), CuI (0.114 g, 0.601 mmol) and 8-hydroxyquinoline (0.087 g, 0.60 mmol) were 
suspended in DMF (10 mL) in a pre-dried sealable tube. The tube was sealed and heated at 
125 °C for 72 h. The reaction mixture was then allowed to cool to room temperature and 
diluted with DCM (75 mL). The mixture was filtered through a pad of Celite and washed with a 
solution of 5% LiCl(aq.) (4 x 100 mL) and brine (100 mL). The solution was then dried (MgSO4) 
and the volatiles removed in vacuo to give a green residue that was redissolved in DCM (30 
mL). Hexane (70 mL) was then added and a solid precipitate removed by filtration. Volatiles 
were removed in vacuo to give 5 as a pale yellow powder (1.592 g, 83%) m.p. 142-144 °C. 
δH(300 MHz, d4-MeOH) 1.11 (12H, d, J = 6.8, CH(CH3)2), 3.11 (2H, sept, J =6.8, CH(CH3)2), 
5.83 (1H, br s, NH), 6.17 (1H, d, J = 8.2, ArH), 6.74 (1H, t, J = 7.2, ArH), 7.10 – 7.32 (m, 6H, 
ArH), 7.50 – 8.40 (2H, br, ArH); δC(75 MHz, CDCl3) 23.0 (CH(CH3)2), 24.4 (CH(CH3)2), 28.4 
(CH(CH3)2), 112.7, 117.3, 124.0, 127.2,127.9, 130.1, 133.6, 143.6, 147.4 (aromatic C); 
υmax/cm-1 (solid) 3205 w, 2961 w, 2868 w, 1603 m, 1586 w, 1511 s, 1493 m, 1465 m, 1453 m, 
1310 m, 1057 m. m/z (ESI) 320 (100%, M+H+); HRMS (FAB) C21H25N3 calcd. 320.21202, 
found 320.21208. Anal. Calcd. for C21H25N3: C, 78.96; H, 7.89; N, 13.15. Found C, 79.03; H, 
7.48; N, 13.04%. Some signals are broad or not apparent in the NMR spectra; we speculate 
that this is due to inter- and intramolecular H-bonding. 
N-(2-(3-iso-propyl-1H-imidazolium)phenyl)-2,6-diisopropylaniline iodide (6) 
In a sealable tube under an atmosphere of air, i-propyl iodide (0.35 mL, 3.4 mmol) was added 
to a green suspension of 5 (1.00 g, 3.14 mmol) in MeCN (10 mL). The tube was sealed and 
heated at 90 °C for 48 h, giving a red solution. The mixture was allowed to cool to RT and 
filtered through Celite. The volatiles were removed in vacuo to give a brown solid that was 
purified by two precipitations from MeOH (5 mL) upon addition of Et2O (80 mL), giving 6 (1.138 
g, 74%) as a white solid m.p. 228-230 °C. δH(300 MHz, CDCl3) 1.11 (6H, d, J = 6.8, 
CH(CH3)2), 1.21 (6H, d, J = 6.8, CH(CH3)2), 1.75 (6H, d, J = 6.7, NCH(CH3)2), 3.14 (2H, sept, J 
= 6.8, CH(CH3)2), 5.19 (1H, sept, J = 6.7, CH(CH3)2, 6.27 (1H, s, NH), 6.34 (1H, d, J = 8.4, 
ArH), 6.80 (1H, td, 3J = 7.6, 4J = 1.1, ArH), 7.20 (1H, t, J = 8.4, ArH), 7.21 (2H, d, J = 7.0, ArH), 
7.28 – 7.34 (2H, m, ArH), 7.54 (1H, ap t, J = 1.7, NCHCHN), 7.64 (1H, ap t, J = 1.7, 
NCHCHN), 9.36 (1H, br s, NCHN); δC(75 MHz, CDCl3) 22.7 (CH(CH3)2),  23.4 (CH(CH3)2), 
24.9 (CH(CH3)2), 28.4 (CH(CH3)2), 54.0 (NCH(CH3)2), 115.3, 118.1, 120.0, 122.0, 123.4, 
124.2, 127.4, 127.9, 131.8, 133.4, 135.3, 143.0, 147.3 (aromatic C). υmax/cm-1 (solid) 3215 w, 
3070 w, 2962 m, 2867 w, 1608 m, 1563 w, 1549 w, 1505 s, 1463 m, 1432 w, 1303 m, 1199 w, 
1120 w, 1048 w, 797 m, 743 vs. m/z (ESI) 362 (100 % [M-I]+); HRMS (FAB) C24H32N3 calcd. 
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362.25882, found 362.25878. Anal. Calcd. for C24H32IN3: C, 58.90; H, 6.59; N, 8.59. Found C, 
59.07; H, 6.29; N, 8.69%. 
Palladium bis(2-(3-iso-propylimidazolin-2-yliden-1-yl)phenyl)amide iodide, [CNC-i-Pr]PdI 
(7a) 
A solution of Pd(OAc)2 (0.026 g, 0.12 mmol) and the imidazolium salt 3a (0.075 g, 0.12 mmol) 
in DME (15 mL) was cooled to 0 °C and a solution of 1 M KHMDS in toluene (0.36 mL, 0.36 
mmol) added dropwise with stirring. The flask was stirred for 6 h at 0 °C and then allowed to 
warm to RT overnight. The crude reaction mixture was filtered through Celite and the solvent 
removed in vacuo to give a red-brown solid. The solid was dissolved in DCM (ca. 20 mL) and 
the solution decanted to remove insoluble material. Purification by flash column 
chromatography (33% EtOAc/pet. ether) gave 7a (0.024 g, 33%) as an orange solid m.p. 272-
275 °C, Rf = 0.37 (33% EtOAc/pet. ether). Crystals of 7a suitable for structure determination 
by X-ray diffraction were obtained by slow evaporation of a solution of 7a in C6D6. δH(300MHz, 
C6D6) 0.71 (6H, d, J = 6.7, CH3), 1.32 (6H, d, J = 6.7, CH3), 6.23 (2H, d, J = 1.8,  NCHCHN), 
6.35 (2H, apparent sept, J = 6.7, CH(CH3)2), 6.60 (2H, t, J = 7.8, CH), 6.71 (2H, d, J = 1.8, 
NCHCHN), 6.81 (2H, t, J = 7.8, CH), 6.99 (2H, d, J = 7.8, CH), 7.09 (2H, d, J = 7.8, CH); 
δC(75MHz, C6D6) 23.2 (CH(CH3)2), 23.7 (CH(CH3)2), 53.5 (CH(CH3)2), 117.7, 118.9 
(NCHCHN), 119.2 (NCHCHN), 121.3, 122.8, 127.4, 133.5, 144.7, 165.3 (N2C-Pd); υmax/cm-1 
(solid) 2962w, 2926w, 2870w, 1587w, 1487s, 1449m, 1403m, 1334s, 1266m, 1216m, 1132m, 
1077w, 1039w, 882w, 842w, 743s, 728s, 682s. m/z  (ESI) 490 (65%, [M-I]+), 531 (100%, [M-
I+MeCN]+); (FAB) 617 [M]+; HRMS C24H26N5Pd ([M-I]+) calcd. 490.1227, found 490.1239. 
Anal. Calcd for C24H26IN5Pd:  C, 46.66, H, 4.24, N, 11.34.  Found:  C, 46.70, H, 4.22, N, 
11.37%. 
Palladium bis(2-(3-n-butylimidazolin-2-yliden-1-yl)phenyl)amide iodide, [CNC-n-Bu]PdI 
(7b) 
Complex 7b was prepared in an identical procedure to that for 7a, using Pd(OAc)2 (0.067 g, 
0.30 mmol), 3b (0.200 g, 0.299 mmol), DME (15 mL) and a solution of KHMDS in toluene (1 
M, 0.90 mL, 0.90 mmol). Purification by flash column chromatography (33% EtOAc/pet. ether) 
gave 7b (0.082 g, 42%) as an orange solid m.p. 106-108 °C, Rf = 0.37 (33% EtOAc/pet. 
ether). Crystals of 7b suitable for structure determination by X-ray diffraction were obtained by 
slow evaporation of a solution of 7b in C6D6. δH(300 MHz, C6D6) 0.72 (6H, t, J= 7.4, CH3), 
0.96-1.24 (4H, m, NCH2CH2CH2CH3), 1.25-1.43 (2H, m, NCH2CH2CH2CH3), 1.70-1.87 (2H, m, 
NCH2CH2CH2CH3), 4.12-4.24 (2H, m, NCH2CH2CH2CH3), 4.61-4.73 (2H, m, 
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NCH2CH2CH2CH3), 6.10 (2H, d, J = 2.0, NCH2CH2N), 6.61 (2H, t, J = 7.6, CH), 6.64 (2H, d, J 
= 2.0, NCH2CH2N), 6.81 (2H, t, J = 7.6, CH), 7.00 (2H, d, J = 7.6, CH), 7.03 (2H, d, J = 7.6, 
CH); δC(75MHz, C6D6) 14.2 (CH3), 19.9 (NCH2CH2CH2CH3), 33.8 (NCH2CH2CH2CH3), 52.7 
(NCH2CH2CH2CH3), 118.0 (NCH2CH2N), 119.2, 121.7, 123.0, 123.2, 127.9, 134.1, 145.2, 
167.0 (N2C-Pd); υmax/cm-1 (solid) 2952 w, 2868 w, 1588 w, 1487 s, 1451 m, 1416 m, 1336 m, 
1269 m, 1133 w, 1073 w, 1039 w, 952 w, 880 w, 745 s, 724 s, 696 s, 683 s. m/z  (ESI) 518 
(20%, [M-I]+), 559 (100%, [M-I+MeCN]+) (FAB) 645 [M]+; HRMS C26H30N5Pd ([M-I]+) calcd. 
518.1557, found 518.1517; Anal. Calcd for C26H30IN5Pd: C, 48.35; H, 4.68; N, 10.84. Found C, 
48.41; H, 4.68; N, 10.74%. 
Platinum bis(2-(3-iso-propylimidazolin-2-yliden-1-yl)phenyl)amide iodide, [CNC-i-Pr]PtI 
(8a) 
A solution of PtCl2(cod) (0.292 g, 0.780 mmol) and 3a (0.500 g, 0.780 mmol) in THF (15 mL) 
was cooled to -78 °C and a solution of 0.55 M KHMDS in toluene (5.00 mL, 2.73 mmol) added 
dropwise with stirring. The flask was stirred for 8 h at -78 °C and then allowed to warm to RT 
overnight. The crude reaction mixture was filtered through Celite and the solvent removed 
under reduced pressure to give a yellow-orange solid.  The solid was dissolved in DCM (ca. 20 
mL) and the solution decanted to remove insoluble salts. Purification by flash column 
chromatography (20% EtOAc/hexane) gave 8a (0.043 g, 9%) as a yellow solid m.p. 287-289 
°C, Rf = 0.26 (20% EtOAc/hexane). δH(300 MHz, C6D6) 0.73 (6H, d, J = 6.9, CH3), 1.37 (6H, d, 
J = 6.9, CH3), 6.19 (2H, d, J = 2.2, NCHCHN), 6.38 (2H, apparent sept, J = 6.9, CH(CH3)2), 
6.60 (2H, t, J = 7.8, CH), 6.68 (2H, d, J = 2.2, NCHCHN), 6.78 (2H, t, J = 7.8, CH), 6.95 (2H, d, 
J = 7.8, CH), 7.09 (2H, d, J = 7.8, CH); δC(125MHz, CD2Cl2) 23.4 (CH(CH3)2), 24.1 (CH(CH3)2-
), 53.2 (CH(CH3)2), 118.5, 118.8 (NCHCHN), 119.4 (NCHCHN), 121.0, 122.2, 127.1, 133.1, 
144.0, 162.5 (N2C-Pt); υmax/cm-1 (solid) 3061 w, 2971 w, 1563 w, 1489 s, 1451 m, 1401 m, 
1340 s, 1268 m, 1214 m, 1131 w, 1079 w, 1037 w, 951 w, 889 w, 723 s, 690 s. m/z  (ESI) 620 
(25%, [M-I+MeCN]+), 579 (100% [M-I]+); m/z (FAB)  706 [M]+; Anal. Calcd. for C24H26IN5Pt: C, 
40.80; H, 3.71; N, 9.91. Found C, 40.82; H, 3.75; N, 9.91%. 
Platinum bis(2-(3-n-butyl-imidazolin-2-yliden-1-yl)phenyl)amide iodide, [CNC-n-Bu]PtI 
(8b) 
Complex 8b was prepared in an identical procedure to that for 8a, using PtCl2(cod) (0.280 g, 
0.747 mmol), 3b (0.500 g, 0.747 mmol), THF (15 mL) and a solution of 1M KHMDS in toluene 
(2.24 mL, 2.24 mmol). Purification by flash column chromatography (33% EtOAc/pet. ether) 
gave 8b (0.057 g, 12%) as a yellow solid m.p. 169-171 °C, Rf = 0.25 (33% EtOAc/pet. 
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ether). δH(500MHz, CD2Cl2) 0.84 (6H, t, J= 7.4, CH3), 1.27 (4H, m, CH2CH3), 1.74 (2H, m, 
CH2CH2CH3), 1.98 (2H, m, CH2CH2CH3), 4.52 (4H, m, CH2CH2CH2CH3), 6.76 (2H, t, J = 7.3, 
CH), 6.92 (4H, m, CH), 7.12 (2H, d, J = 2.0, NCHCHN), 7.37 (2H, d, J = 8.0, CH), 7.45 (2H, d, 
J = 2.0, NCHCHN); δC(125 MHz, CD2Cl2) 14.0 (CH3), 19.9 (CH2CH3), 33.5 (CH2CH2CH3), 52.5 
(CH2CH2CH2CH3), 118.7, 118.8 (NCHCHN), 121.3, 122.4, 123.1 (NCHCHN), 127.4, 133.4, 
144.2, 164.0 (N2C-Pt); υmax/cm-1 (solid) 2957 w, 2872 w, 1587 w, 1562 w, 1487 s, 1448 m, 
1414 m, 1387 m, 1327 s, 1270 s, 1232 m, 1134 w, 1041 w, 951 m, 888 w, 717 s, 685 s. m/z  
(ESI) 735 (10%, [M+H]+), 607 (100%, [M-I]+); Anal. Calcd. for C26H30IN5Pt: C, 42.51; H, 4.12; 
N, 9.53. Found C, 42.55; H, 4.17; N, 9.57%. 
Pyridyl palladium bis(2-(3-iso-propylimidazolin-2-yliden-1-yl)phenyl)amide triflate, 
{[CNC-i-Pr]Pd-(d5-py)}OTf (9a) 
Iodide complex 7a (0.012g, 0.019 mmol) was dissolved in d5-pyridine and AgOTf added 
(0.007g, 0.03 mmol). Crystals of 9a suitable for structure determination by X-ray diffraction 
were obtained by diffusion of pentane into this solution. Attempts to isolate an analytically pure 
sample of 9a on a larger scale were unsuccessful as it was not possible to completely 
separate 9a from pyridine. δH(400 MHz, d5-pyridine) 0.72 (6H, d, J = 6.7, CH3), 0.90 (6H, d, J = 
6.7, CH3), 3.68 (2H, apparent sept, J = 6.7, CH(CH3)2), 6.96 (2H, t, J = 7.9, CH), 7.08 (2H, t, J 
= 7.9, CH), 7.17 (2H, d, J = 7.9, CH), 7.64 (2H, d, J = 2.1, NCHCHN), 7.76 (2H, d, J = 7.9, 
CH), 8.14 (2H, d, J = 2.1, NCHCHN); δC(125 MHz, d5-pyridine) 21.9 (CH3), 23.8 (CH3), 51.7 
(CH(CH3)2), 119.3, 120.2, 120.3, 121.8, 124.6, 128.1, 132.3, 143.8, 163.8 (N2C-Pd); 19F NMR 
(282 MHz, d5-pyridine) δ -77.2. m/z  (ESI) 490 (65%, [M-OTf-py]+), 531 (100%, [M-OTf-
py+MeCN]+). 
Pyridyl palladium N-(2-(3-iso-propylimidazolin-2-yliden-1-yl)phenyl)-2,6-
diisopropylaniline diiodide, [C,NH]PdI2py (10) 
Imidazolium salt 6 (0.150 g, 0.307 mmol), PdCl2 (0.050 g, 0.28 mmol), K2CO3 (0.193 g, 1.40 
mmol) and KI (0.232 g, 1.40 mmol) were suspended in pyridine (10 mL) and heated at 100 °C 
for 18 h. After cooling to RT, the reaction mixture was diluted with DCM (30 mL), filtered 
through Celite and the volatiles removed in vacuo. Purification by flash column 
chromatography (17% EtOAc/pet. ether) gave 10 as a yellow-orange solid (0.199 g, 89%) m.p. 
122-123 °C, Rf = 0.18 (17% EtOAc/pet. ether). Crystals suitable for structure determination by 
X-ray diffraction were obtained by diffusion of hexane into a saturated DCM solution of 10. 
δH(300 MHz, CD2Cl2) 1.11 (12H, br d, J = 6.8, CH(CH3)2), 1.62 (6H, d, J = 6.8, NCH(CH3)2), 
3.15 (1H, br, CH(CH3)2), 3.48 (1H, br, CH(CH3)2), 5.27 (1H, s, NH), 5.79 (1H, sept, J = 6.8, 
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NCH(CH3)2), 6.32 (1H, d, J = 8.2, ArH), 6.94 (1H, t, J = 7.6, ArH), 7.17-7.35 (8H, m), 7.74 (1H, 
t, J = 7.6, pyH), 7.16 (1H, d, J = 7.9, ArH), 8.88 (2H, br d, J = 4.9, pyH); δC(125.8 MHz, C6D6) 
21.9 (NCH(CH3)2), 22.3 (CH(CH3)2), 22.7 (CH(CH3)2), 25.0 (CH(CH3)2), 25.5 (CH(CH3)2), 28.5 
(CH(CH3)2), 28.7 (CH(CH3)2), 53.9 (NCH(CH3)2), 116.1, 117.7, 118.8, 123.8, 124.2, 124.9, 
125.1, 127.0, 127.6, 130.4, 131.5, 135.4, 136.8, 144.0, 146.6 (Ar/py C), 147.3 (N2CPd), 148.0 
(Ar C), 154.1 (py CH). υmax/cm-1 (solid) 3386 w (NH), 2965  m, 2865 w, 1603  m, 1506 m, 1444 
m, 1430 m, 1362 w, 1326 m, 1300 m, 1240 w, 1210 m, 1111 w, 1070 w, 1045 w, 1020 w, 957 
w, 937 w, 880 w, 803 m, 754 s, 726 m, 685 s. m/z (ESI) 466 (100 % [M-I-HI-py]+); 507 (70 % 
[M-I-HI-py+MeCN]+). Anal. Calcd. for C29H36I2N4Pd: C, 43.49; H, 4.53; N, 7.00. Found C, 
43.51; H, 4.45; N, 7.12%. 
Pyridyl platinum N-(2-(3-iso-propylimidazolin-2-yliden-1-yl)phenyl)-2,6-
diisopropylaniline diiodide, [C,NH]PtI2py (11) 
Imidazolium salt 6 (0.400 g, 0.818 mmol), K2PtCl4 (0.309 g, 0.744 mmol), K2CO3 (0.513 g, 
3.72 mmol) and KI (0.617 g, 3.72 mmol) were suspended in pyridine (15 mL) and heated at 
100 °C for 48 h. After cooling to RT, the reaction mixture was diluted with DCM (30 mL), 
filtered through Celite and the volatiles removed in vacuo. Purification by flash column 
chromatography (13% EtOAc/pet. ether) followed by crystallisation from Et2O/pentane gave 11 
(0.313 g, 47%) as yellow crystals m.p. 206-208 °C (dec.), Rf = 0.3 (13% EtOAc/pet. ether). 
Crystals suitable for structure determination by X-ray diffraction were obtained by slow 
evaporation of a saturated DCM solution of 11. δH(300 MHz, CD2Cl2) 1.11 (12H, d, J = 6.5, 
CH(CH3)2), 1.60 (6H, d, J = 6.7, NCH(CH3)2), 3.10 (1H, br, CH(CH3)2), 3.53 (1H, br, 
CH(CH3)2), 5.99 (1H, sept, J = 6.7, NCH(CH3)2), 6.30 (1H, d, J = 8.2, ArH), 6.90 (1H, t, J = 7.6, 
ArH), 7.14-7.33 (8H, m, CH), 6.73 (1H, t, J = 7.6, pyH), 8.01 (1H, d, J = 7.9, ArH), 8.90 (2H, d, 
J = 5.3, pyH); δC(125.8 MHz, CD2Cl2) 22.4 (NCH(CH3)2), 22.8 (CH(CH3)2), 24.4 (CH(CH3)2), 
25.0 (CH(CH3)2), 25.5 (CH(CH3)2), 28.2 (CH(CH3)2), 28.8 (CH(CH3)2), 53.1 (NCH(CH3)2), 
115.1, 117.3, 117.9, 124.2, 124.6, 125.2, 126.7, 127.6, 129.9, 131.2, 135.1, 136.7, 137.9 
(Ar/py C), 143.6 (N2CPt), 147.2, 148.2 (Ar C), 154.1 (py C). υmax/cm-1 (solid) 3389 w (NH), 
2966 m, 2866 w, 1605 m, 1445 m, 1416 m, 1370 w, 1328 m, 1300 m, 1240, 1210 m, 1117 w, 
1071 w, 1043 w, 1022 w, 958 w, 938 w, 883 w, 800 m, 758 s, 730 m, 693 s. m/z (ESI) 555 
(100 % [M-I-HI-py]+); 634 (10 % [M-I-HI-py+MeCN]+). Anal. Calcd. for C29H36I2N4Pt: C, 39.16; 
H, 4.08; N, 6.30. Found C, 39.27; H, 4.17; N, 6.18%. 
Hydroxy palladium N-(2-(3-iso-propylimidazolin-2-yliden-1-yl)phenyl)-2,6-
diisopropylphenylamide dimer, {[C,N]Pd(µ-OH)}2 (12) 
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A solution of complex 10 (0.100 g, 0.125 mmol) in 1,4-dioxane (18 mL) was stirred vigorously 
with a solution of KOH (0.350g, 6.250 mmol) in H2O (3 mL) at 40 °C for 24 h. After cooling to 
RT, the volatiles were removed in vacuo. The crude solid was re-dissolved in DCM (15 mL), 
dried (MgSO4) and filtered through Celite. Removing the solvent under reduced pressure gave 
12 (0.076 g, 63%) as an orange/red powder m.p. 190 °C (dec.). Crystals suitable for structure 
determination by X-ray diffraction were obtained by slow evaporation of an Et2O/pentane 
solution of 12. δH(300 MHz, CD2Cl2) -3.97 (2H, s, OH), 0.96 (12H, d, J = 6.9, CH(CH3)2), 1.11 
(12H, d, J = 6.7, NCH(CH3)2), 1.46 (12H, d, J = 6.9, CH(CH3)2), 3.49 (4H, sept, J = 6.9, 
CH(CH3)2), 5.17 (2H, sept, J = 6.7, NCH(CH3)2), 5.80 (2H, d, J = 8.1, CH), 6.23 (2H, t, J = 7.7, 
CH), 6.63 (2H, t, J = 8.1, CH), 7.02 (2H, d, J = 2.2, NCHCHN), 7.08 (6H, br s, 2,6-iPr2C6H3), 
7.22 (2H, d, J = 7.7, CH), 7.50 (2H, d, J = 2.2, NCHCHN); δC(75 MHz, C6D6) 23.8 (CH(CH3)2), 
24.7 (CH(CH3)2), 25.5 (CH(CH3)2), 28.1 (CH(CH3)2), 50.1 (NCH(CH3)2), 110.8, 117.4, 117.7, 
117.8, 118.9 (ArCH), 122.9 (ArC), 124.7, 125.2, 126.7 (ArCH), 144.7, 145.7, 147.4, 147.5 
(4°C). υmax/cm-1 (solid) 3601 w (OH), 2961 m, 2863 w, 1598 m, 1493 s, 1455 m, 1426 m, 1410 
m, 1356 s, 1337 s, 1284 m, 1221 m, 1161 w, 1124 w, 1081 w, 1055 m, 952 w, 850 s, 825 m, 
801 m, 767 m, 735 s, 723 s, 713 s, 693 m, 672 s. m/z (ESI, 25 V) 466 (100% [(C,N)Pd]+), 500 
(100% [(C,N)Pd(OH)2]–). Anal. Calcd. for C48H62N6O2Pd2: C, 59.56; H, 6.46; N, 8.68. Found C, 
59.47; H, 6.30; N, 8.73 %. 
X-ray Crystallographic Studies 
All single crystal diffraction data were collected using graphite-monochromated Mo Kα X-
radiation (λ = 0.71073 Å ) on a Bruker APEX 2000 CCD diffractometer at 150 K. The data 
were corrected for Lorentz and polarisation effects and empirical absorption corrections 
applied. Structures were solved by Patterson methods and structures refined by least-squares 
full-matrix refinement against F2 employing SHELXTL version 6.10.75 Hydrogen atoms were 
included in calculated positions (d(C-H) = 0.95 to 0.99 Å) riding on the bonded atom with 
isotropic displacement parameters set to 1.5 Ueq(C) for methyl H atoms and 1.2 Ueq(C) for all 
other C atoms. All non-H atoms were refined with anisotropic displacement parameters. 
Crystal data for 7a·(2C6H6). C36H38IN5Pd, Mw = 774.01 gmol-1, T = 150(2) K, orthorhombic 
space group C222(1), a = 10.8012(19) Å, b = 19.746(4), c = 15.230(3) Å, α = β = γ = 90°, V = 
3248.2(10) Å3, Z = 4, ρcalcd = 1.583 Mgm-3, µ = 1.555 mm-1, F(000) = 1552, crystal size 0.33 x 
0.26 x 0.21 mm3, 13040 reflections collected, 3336 unique [R(int) = 0.0341] which were used 
in all calculations. Empirical absorption correction made, Tmin and Tmax 0.831 and 0.646 
respectively. GOF = 1.064, final R indices [I>2σI] R1 = 0.0260, wR2 = 0.0661, R indices (all 
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data) R1 = 0.0277, wR2 = 0.0667. Largest diff. peak and hole 0.692 and –0.554 e Å-3. 
Disordered C6H6 was omitted using the SQUEEZE option of PLATON.76 The solvent 
accessible voids are 1128.7 Å3 with an estimated 375e/cell to be added. Eight solvent C6H6 
molecules/unit cell accounting for 336e were included in the formula, FWt, (000) and density 
calculations.  
Crystal data for 7b·(C6H6). C32H36IN5Pd, Mw = 723.96 gmol-1, T = 150(2) K, orthorhombic 
space group Aba2, a = 29.370(5) Å, b = 20.178(3) Å, c = 10.3042(17) Å, α = β = γ = 90°, V = 
6106.4(18) Å3, Z = 8, ρcalcd = 1.575 Mgm-3, µ = 1.648 mm-1, F(000) = 2896, crystal size = 0.15 
x 0.14 x 0.10 mm3, 23246 reflections collected, 5940 unique [R(int) = 0.0843] which were used 
in all calculations. Empirical absorption correction made, Tmin and Tmax 0.802 and 0.628 
respectively. GOF = 0.934, final R indices [I>2σI] R1 = 0.0457, wR2 = 0.0751, R indices (all 
data) R1 = 0.0594, wR2 = 0.0790. Largest diff. peak and hole 0.894 and -1.009 e Å-3. 
Crystal data for 9a·(0.75CH2Cl2). C30.75H32.50Cl1.50F3N6O3PdS, Mw = 782.76 gmol-1, T = 150(2) 
K, triclinic space group P-1, a = 10.372(4) Å, b = 11.933(5) Å, c = 26.284(11) Å, α = 
101.593(10)°, β = 94.150(9)°, γ = 95.257(10)°, V = 3159(2) Å3, Z = 4, ρcalcd = 1.646 Mgm-3, µ = 
0.842 mm-1, F(000) = 1590, crystal size 0.22 x 0.13 x 0.02 mm3, 25010 reflections collected, 
12296 unique [R(int) = 0.2109] (completeness to theta = 26.00° 98.9 %). Empirical absorption 
correction made, Tmin and Tmax = 0.802 and 0.338 respectively. GOF = 0.795, final R indices 
[I>2σI] R1 = 0.0910, wR2 = 0.1639, R indices (all data) R1 = 0.1872, wR2 = 0.1958. Largest diff. 
peak and hole 1.347 and -2.118 e Å-3. 
Disordered CH2Cl2 was omitted using the SQUEEZE option of PLATON.76 The solvent 
accessible voids are 207.5 Å3 with an estimated 124 e/cell to be added. Three solvent CH2Cl2 
molecules/unit cell accounting for 126 e were included in the formula, FWt, (000) and density 
calculations. The CF3 group of one of the triflate anions was disordered and one of the F 
atoms has been split; attempts to split other atoms failed. 
Crystal data for 10·(0.5CH2Cl2)(0.25C6H14). C31H40.50ClI2N4Pd, Mw = 864.82 gmol-1, T = 
150(2) K, triclinic space group P-1, a = 13.616(9) Å, b = 15.293(10) Å, c = 18.724(13) Å, α = 
73.804(12)°, β = 73.014(12)°, γ = 64.088(12)°, V = 3302(4) Å3, Z = 4, ρcalcd = 1.740 Mgm-3, µ = 
2.539 mm-1, F(000) = 1694, crystal size 0.20 x 0.20 x 0.13 mm3, 25832 reflections collected, 
12785 unique [R(int) = 0.0875] (completeness to theta = 26.00° 98.6 %). Empirical absorption 
correction made, Tmin and Tmax = 0.831 and 0.455 respectively. GOF = 0.952, final R indices 
[I>2σI] R1 = 0.0589, wR2 = 0.1341, R indices (all data) R1 = 0.0825, wR2 = 0.1428. Largest diff. 
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peak and hole 2.244 and -0.858 e Å-3. 
Disordered CH2Cl2 and C6H14 were omitted using the SQUEEZE option of PLATON.76 The 
solvent accessible voids are 325.1 Å3 with an estimated 144e/cell to be added. Two solvent 
CH2Cl2 molecules and one C6H14 molecule/unit cell accounting for 134e were included in the 
formula, FWt, (000) and density calculations. 
Crystal data for 11. C29H36I2N4Pt, Mw = 889.51 gmol-1, T = 150(2) K, triclinic space group P-
1, a = 13.412(3) Å, b = 15.242(3) Å, c = 18.357(4) Å, α= 95.858(4)°, β= 104.069(4)°, γ = 
114.812(4)°, V = 3214.0(12) Å3, Z = 4, ρcalcd = 1.838 Mgm-3, µ = 6.309 mm-1, F(000) = 1688, 
crystal size 0.23 x 0.08 x 0.04 mm3, 25327 reflections collected, independent reflections 12490 
[R(int) = 0.0920] (completeness to theta = 26.00° 98.80%). Empirical absorption correction 
made, Tmin and Tmax = 0.831 and 0.518 respectively. GOF = 0.897, final R indices [I>2σI] R1 = 
0.0602, wR2 = 0.1004, R indices (all data) R1 = 0.1104, wR2 = 0.1130. Largest diff. peak and 
hole 3.255 and -1.506 e.Å-3. 
Crystal data for 12·(C5H12). C53H74N6O2Pd2, Mw = 1039.98 gmol-1, T = 150(2) K, tetragonal 
space group I4(1)/a, a = 19.443(2) Å, b = 19.443(2) Å, c = 25.426(4) Å, α= 90°, β= 90°, γ = 
90°, V = 9612(2) Å3, Z = 8, ρcalcd = 1.437 Mgm-3, µ = 0.796 mm-1, F(000) = 4336, crystal size 
0.31 x 0.24 x 0.15 mm3, 37121 reflections collected, independent reflections 4713 [R(int) = 
0.0767] (completeness to theta = 26.00° 100.00%). Empirical absorption correction made, Tmin 
and Tmax = 0.802 and 0.634 respectively. GOF = 1.029, final R indices [I>2σI] R1 = 0.0378, 
wR2 = 0.0914, R indices (all data) R1 = 0.0497, wR2 = 0.0960. Largest diff. peak and hole 
0.690 and -0.388 e.Å-3. 
Disordered pentane (C5H12) was omitted using the SQUEEZE option of PLATON.76 The 
solvent accessible voids are 1135.0 Å3 with an estimated 332e/cell to be added. Eight solvent 
C5H12 molecules/unit cell accounting for 336e were included in the formula, FWt, (000) and 
density calculations. 
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Ilustrations 
Fig. 1. Pd [CNC] complexes similar to those reported herein. 
NN
N
N N
Pd Cl
tBu
tBu
A
NN
N
N N
Pd Cl
R
R
B
R = n-Bu, Bn, 
2,4,6-trimethylbenzyl  
Fig. 2. ORTEP view of 7a (ellipsoids drawn at 50% probability). Hydrogen atoms except H(10) 
have been omitted for clarity. 
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Fig. 3. ORTEP view of 7b (ellipsoids drawn at 50% probability). Hydrogen atoms have been 
omitted for clarity. 
 
Fig. 4. ORTEP view of one of the independent cations of 9a (ellipsoids drawn at 50% 
probability). Hydrogen atoms have been omitted for clarity. 
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Fig. 5. ORTEP view of one of the independent molecules of 10 (ellipsoids drawn at 50% 
probability). Hydrogen atoms except H(1) have been omitted for clarity. 
 
Fig. 6. ORTEP view of one of the independent molecules of 11 (ellipsoids drawn at 50% 
probability). Hydrogen atoms except H(1) have been omitted for clarity. 
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Fig. 7. ORTEP view of 12 (ellipsoids drawn at 50% probability). Hydrogen atoms except H(1) 
have been omitted for clarity. 
 
Scheme 1. Synthesis of the amine bis(imidazolium) pro-ligands 3a and 3b.a 
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Scheme 2. Synthesis of the amine imidazolium pro-ligand 6.a 
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CuI (10 mol%), 8-hydroxyquinoline (10 mol%), 
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Scheme 3. Synthesis of palladium and platinum [CNC] complexes. 
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Scheme 4. Synthesis of amine-NHC complexes 10 and 11 and the amido-NHC complex 12. 
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Table 1. Selected bond lengths (Å) for 7a, 7b and 9a. 
 7a 7b 9a 
   molecule 
1 
molecule 
2 
M-N(amide) 2.023(3) 2.020(4) 2.022(8) 2.016(8) 
M-C(NHC) 2.024(3) 2.020(6) 2.00(1) 2.027(11) 
 2.024(3) 2.019(6) 2.036(9) 2.034(10) 
M-N(py)    –    – 2.054(8) 2.072(11) 
M-I 2.5887(6) 2.6034(6) – – 
 
Table 2. Selected bond lengths (Å) for 10, 11 and 12. 
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 10 11  12 
 molecule 1 molecule 2 molecule 1 molecule 2  
M-N(amide) – – – – 1.998(3) 
M-C(NHC) 1.957(7) 1.981(7) 1.965(13) 1.968(11) 1.945(3) 
M-N(py) 2.121(6) 2.086(6) 2.094(10) 2.102(8) – 
M-I 2.5902(18) 
2.6063(17) 
2.5889(16) 
2.6054(15) 
2.5901(10) 
2.6024(10) 
2.5969(11) 
2.6060(10) 
– 
– 
M-O1 
M-O1’ 
– 
– 
– 
– 
– 
– 
– 
– 
2.052(2) 
2.086(2) 
 
 
 
 
